Safety of the blood supply in Latin America

Clinical Microbiology Reviews

Volumn 18, Issue 1, 2005, Pages 12-29

  Schmunis, Gabriel A ^a   Cruz, Jose R ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; HEALTH STATUS; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFORMATION SYSTEM; LAW; QUALITY CONTROL; REVIEW; SAFETY; SCREENING TEST; SOUTH AND CENTRAL AMERICA;

BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; LATIN AMERICA; VIRUS DISEASES;

EID: 12844279876     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.18.1.12-29.2005     Document Type: Review

References (129)

1. Aach, R. D., C. E. Stevens, F. B. Hollinger, J. W. Mosley, D. A. Petersen, P. E. Taylor, R. G. Johnson, L. H. Barbosa, and G. J. Nemo. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N. Engl. J. Med. 325:1325-1329.
2. Akhavan, D. 2000. Analise custo-efetividade do programa de controle da doenca de Chagas no Brasil, p. 7-9. Organizacao Pan-Americana da Saude, Brasilia, Brazil.
3. Allain, J. P. 2003. Transfusion risks of yesterday and today. Transfusion Clin. Biol. 10:1-5.
4. Alter, M. 1995. Residual risk of transfusion associated hepatitis, p. 23-27. In Program and Abstracts of the National Institutes of Health Development Conference on Infectious Diseases Testing for Blood Transfusion. National Institutes of Health, Bethesda, Md.
5. Attias, A, M. Lorca, M. Canales, R. Mercado, V. Reyes, and R. Child. 1984. Bol. Hosp. San Juan de Dios (Santiago) 31:301-306.
6. Beal, R. W., and W. G. van Aken. 1992. Gift or good? A contemporary examination of the voluntary and commercial aspects of blood donation. Vox Sang. 63:1-5.
7. Beltran, M. D., and M. G. Ayala. 2003. Evaluacion externa de los resultados serologicos en los bancos de sangre de Colombia. Rev. Salud Publica 13:138-143.
8. Bush, M. P. 1995. Incidence of infectious disease markers in blood donors, implications for residual risk of viral transmission by transfusion, p. 29-30. In Program and Abstracts of the National Institutes of Health Development Conference. National Institutes of Health, Bethesda, Md.
9. Centers for Disease Control and Prevention. 2004. Update: West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. Morb. Mortal. Wkly. Rep. 53:281-284.
10. Cerisola, J. A., A. Rabinovich, M. Alvarez, C. A. Di Corleto, and J. Pruneda. 1972. Enfermedad de Chagas y la transfusion de sangre. Bol. Ofic. Sanit. Panam. 73:203-221.
11. Clarin. 1996. Tres millones de pesos. Indemnizan a dos nenas contagiadas de sida. 31 October 1996. Clarín, Buenos Aires, Argentina.
12. Reference deleted.
13. Contreras, M. C., H. Schenone, J. M. Borgono, P. Salinas, L. Sandoval, A. Rojas, and F. Solis. 1992. Infeccion Chagasica en donantes de sangre de hospitales de las regiones endemicas (1982-1987). Trascendencia epidemiologica del problema. Bol. Chile Parasitol. 47:10-15.
14. Couruce, A. M., N. Le Marrec, A. Girault, S. Ducamp, and N. Simon. 1994. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialisis: comparison of second- and third-generation anti-HCV assays. Transfusion 34:790.
15. Cruz, J. R., and M. D. Perez Rosales. 2003. Availability, safety, and quality of blood for transfusion in the Americas. Panam. J. Public Health 13:103-109.
16. Debeir, J., L. Noel, J. P. Aullen, C. Frette, F. Sari, M. Vo Mai, and A. Cosson. 1999. The French haemovigilance system. Vox Sang. 77:77-81.
17. Dias, J. C. P. 1979. Mecanismos de transmissao, p.152-174. In Z. Brener and Z. A. Andrade (ed.), Trypanosoma cruzi e doenca de Chagas. Guanabara Koggan, Rio de Janeiro, Brazil.
18. Dias, J. C. P., and S. Brener. 1984. Chagas disease and blood transfusion. Mem. Inst. Oswaldo Cruz. 79(Suppl.):139-147.
19. Dodd, R. Y., E. P. Notari, and S. L. Stramer. 2002. Current prevalence and incidence of infectious diseases markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42:975-979.
20. Donegan, E., M. Stuart, J. C. Niland, H. S. Sacks, S. P. Azen, S. L. Dietrich, C. Faucett, M. A. Fletcher, S. H. Kleiman, and E. A. Operskalski. 1990. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann. Intern. Med. 113:733-739.
21. Du, K. 2002. The quest for quality blood banking program in the new millennium the American way. Int. J. Hematol. 76(Suppl. 2):258-262.
22. Emmanuel J. 1994. Establishment and organization of a blood transfusion service. Vox Sang. 67(Suppl. 5):4-7.
23. Emmanuel, J. 1999. Servicios o sistemas nacionales de sangre. Rev. Arg. Transfusion 4:301-304.
24. Faber, J. C. 2002. Haemovigilance around the world. Vox Sang. 83(Suppl. 1):71-76.
25. Folha Cotidiano. 2004. Governo volta a adiar novo teste de sangue, p.C1, 17 April 2004. Folha de Sao Paulo, Sao Paulo, Brazil.
26. Folha São Paulo. 1999. Sangue so tera qualidade total em 2003. 15 May 1999. Folha São Paulo, São Paulo, Brazil.
27. Franco, E. 2003. El control de calidad de los analisis immunohematologicos. Rev. Panam. Salud Publica 13:176-182.
28. Garcia, M. G., E. Saenz de Tejada, and J. R. Cruz. 2003. Estudio de factores socioculturales relacionados con la donacion voluntaria de sangre en las Americas. Rev. Panam. Salud Publica 13:85-90.
29. Glynn, S. A., S. H. Kleinman, G. B. Schreiber, M. P. Busch, D. J. Wright, J. W. Smith, C. C. Nass, and A. E. Williams. 2000. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA 284:229-235.
30. Goodman, C., S. Chan, P. Collins, R. Haught, and Y. J. Chen. 2003. Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment-Final report. Transfusion 43(Suppl.):3S-46S.
31. Guzman Bracho, C., L. Garcia Garcia, J. Floriani Verdugo, S. Guerrero Martinez, M. Torres Cosme, C. Ramirez Melgar, and O. Velazco Castrejon. 1998. Riesgo de transmision de Trypanosoma cruzi por transfusion de sangre en Mexico. Rev. Panam. Salud Publica 4:94-98.
32. Hamerschlak, N., J. Pasternak, V. Amato Neto, M. B. Carvalho, C. S. Guerra, A. L. Coscina, et al. 1997. Chagas disease, an algorithm for donor screening and positive donor counseling. Rev. Soc. Brasil. Med. Trop. 30:205-209.
33. Health Canada. 1998. Goverment action on Krever Commision recommendations. [Online.] http://www.hcsc.gc.ca/english/media/relerases/1998 /9889bkcl.htm.
34. Hewitt, P. E., J. A. J. Barbara, and M. Contreras. 1994. Donor selection and microbial screening. Vox Sang. 67(Suppl. 5):14-19.
35. Kaufman, M. 2000. FDA finds problems with Red Cross blood. 2 December 2000. The Washington Post, Washington, D.C.
36. Kessler, D. A. 1993. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA 269: 2765-2768.
37. Kupek, E. J. 2001. The reduction of HIV transfusion risk in Southern Brazil in the 1990s. Transfusion Med. 11:75-78.
38. Kupek, E. J. 2001. Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-1999. J. Viral Hepat. 8:78-82.
39. Lackritz, E. M., G. A. Satten, J. Aberle-Grasse, R. Y. Dodd, V. P. Raimondi, R. S. Janssen, et al. 1995. Estimated risk of transmission of the Human immunodeficiency virus by screened blood in the United States. N. Engl. J. Med. 333:1721-1725.
40. Leikola, J. 1990. Formulation of a national blood programme, p. 1-13. In S. R. Hollan, W. Wagstaff, J. Leikola, and F. Lothe (ed.), Managment of blood transfusion services. World Health Organization, Geneva, Switzerland.
41. Leikola, J., and M. Contreras. 1994. Overview of issues and problems facing blood transfusion services. Vox Sang. 67(Suppl. 5):1-3.
42. Linares, J., and E. Vinelli (ed.). 1994. Taller Latinoamericano de servicios de transfusion de sanguinea y optimo uso de los recursos, p. 167. Cruz Roja Finlandesa, Caracas, Venezuela.
43. Lorca, M. H., R. B. Child, A. C. Garcia, M. G. Silva, J. S. Osorio, and M. Atias. 1992. Evaluacion de reactivos comerciales empleados en el diagnostico de la enfermedad de Chagas en bancos de sangre de Chile. I Seleccion de reactivos. Rev. Med. Chile 120:420-426.
44. Lorca, M. H., R. B. Child, A. C. Garcia, M. G. Silva, P. L. Martinez, G. M. Jerez, I. D. Toledo, and D. A. Mezzano. 1994. Evaluacion de reactivos comerciales empleados en el diagnostico de la enfermedad de Chagas en bancos de sangre de Chile. II. Aplicacion rutinaria. Rev. Med. Chile 122: 925-931.
45. Lorca, M., J. Lorca, R. Chile, A. Attias, M. Canales, E. Lorca, and J. Gutierrez. 1988. Prevalencia de la infeccion por Trypanososma cruzi en pacientes politransfundidos. Rev. Med. Chile 116:112-116.
46. Manitove, J. E. 1999. Haemovigilance systems. Vox Sang. 77:110-120.
47. Marti-Carvajal, A. J., S. R. Munos-Navarro, G. E. Pena-Marti, and G. Comunian. 1999. An audit of appropriate use of blood products in adult patients in a Venezuelan general university hospital. Int. J. Qual. Health Care 11:391-395.
48. McCleland, D. B. L., and P. Phillips. 1994. Errors in blood transfusion in Britain: survey of hospital haematology departments. Br. Med. J. 308:1205-1206.
49. Ministerio de Salud, Chile. 1995. Diagnostico de la situación de los bancos de sangre y medicina transfusional en Chile 1993. Ser. Inf. Tec. no. 14. Ministerio de Salud, Santiago, Chile.
50. Ministerio de Sanidad y Consumo. Direccion General de Salud Publica. 1998. Plan nacional de hemoterapia. Estadistica estatal de centros de transfusion y bancos de sangre. Año 1997, p. 9-11. Espaňa. Junio.
51. Ministerio de Saude. Secretaria de Politicas de Saude. 1998. Coordenacao de sangue e hemoderivados, p. 26 Ministerio de Saude, Relatorio, Brazil.
52. Mora, G., and J. Yunes. 1993. Maternal mortality: an overlooked tragedy, p. 62-79. In Gender, women, and health in the Americas. Scientific Publication 541. Pan American Health Organization, Washington, D.C.
53. Moraes Souza, H., D. M. Wanderley, S. Brener, R. D. Nascimento, C. M. Antunes, and J. C. P. Dias. 1994. Hemoterapia e doença de Chagas transfusional no Brasil. Bol. Ofic. Sanit. Panam. 116:406-418.
54. Mueller-Breitkreutz, K., T. Evers, and R. Perry. 1998. Viral marker rates among unpaid blood donors in Europe decreased from 1990 to 1996. Eurosurveillance 3:71-76.
55. Organización Panamericana de la Salud. 2003. XIIa Reunión de la Comisión Intergubernamental para la eliminación del Triatoma infestans y la interrupción de la tripanosomiasis americana por transfusión. OPS-DPC-CD-270-03. INCOSUR/Chagas. Marzo, Santiago, Chile. OPS, Washington, D.C.
56. Oknaian, S., M. Remesar, L. Ferraro, and A. E. del Pozo. 2003. Evaluacion externa del desempeno en el tamizaje de bancos de sangre en Argentina: resultados y estrategias para mejorarlo. Rev. Panam. Salud Publica 13:149-158.
57. Organización Panamericana de la Salud, Division de Desarrollo de Sistemas de Salud. 1999. Estandares de trabajo para bancos de sangre. OPS, Washington, D.C.
58. Organización Panamericana de la Salud. 1993. Regimen legal de bancos de sangre en America Latina: malaria, Chagas y hepatitis B. Documentos de trabajo. OPS, Washington, D.C.
59. Organización Panamericana de la Salud. 1994. Iniciativa del Cono Sur. III. Reunión de la Comisión Intergubernamental para la Eliminación del Triatoma infestans y la interrupción de la tripanosomiasis Americana transfusional. Montevideo, Uruguay, 21 al 23 de Marzo. OPS/HCP/HCT/94-37. OPS, Washington, D.C.
60. Organizacion Panamericana de la Salud. 1994. Taller para el control de calidad de sangre en transfusiones: serologia para la deteccion de Chagas, hepatitis B y C, sífilis y HIV/SIDA. Document OPS/HPC/HCT/94.42. OPS, Washington, D.C.
61. Organización Panamericana de la Salud. 1995. Simposio internacional sobre control de calidad en bancos de sangre del Cono Sur y de Brasil. Informe final. Document OPS/HPC/HCT/95.55. OPS, Washington, D.C.
62. Organización Panamericana de la Salud. 1995. Taller para el control de calidad de sangre en transfusiones: serologia para la deteccion de Chagas, hepatitis B y C, sífilis y HIV/SIDA. Document OPS/HPC/HCT/95.61. OPS, Washington, D.C.
63. Organización Panamericana de la Salud. 1996. Taller sobre control de calidad de sangre en serologia de bancos de sangre. Document OPS/HPC/ HCT/96/79. OPS, Washington, D.C.
64. Organización Panamericana de la Salud. 1997. Situacion de los bancos de sangre en la Región de las Américas, 1994-1995. Bol. Epidemiol. 18:11-12.
65. Organización Panamericana de la Salud. 2003. Medicina transfusional en America Latina 1994-2002. Document OPS/EV-LAB/01.2003. OPS, Washington, D.C.
66. Otani, M. M. 2003. Programa de avaliacao externa para os testes de triagem sorologica de doadores de banco de sangue dos centros de referencia da America Latina: utilizacao de multipainel especifico. PhD thesis. University of Sao Paulo, Sao Paulo, Brazil.
67. Pan American Health Organization. 1998. Third meeting of the task force on surveillance for emerging and re-emerging infectious diseases, p. 44-50. Mexico City, Mexico, 16-17 November. PAHO/HCP/HCT/141/99. PAHO, Washington, D.C.
68. Pan American Health Organization. 1998. Blood bank situation in Latin America, 1996: serological markers for communicable diseases in blood donors. Epidemiol. Bull. 19:12-14.
69. Pedersen, C., B. O. Lindhardt, B. L. Jensen, E. Lavritzen, J. Gertoff, and E. Dickmeiss. 1989. Clinical course of primary HIV infection, consequences for subsequent course of infection. Br. Med. J. 299:154-157.
70. Perez, A., and E. L. Segura. 1989. Transfusión de sangre y transmisión de la infeccion chagasica en Argentina. Rev. Arg. Transfusion 15:127-132.
71. Pillonel J., C. Saura, and A. M. Courouce. 1998. Screening of viral markers for HIV, HBV and HCV infections in blood donors in France and residual risk of viral transmission by blood transfusion. Eurosurveillance 3:76-79.
72. Pillonel, J, S. Laperche, C. Saura, J. C. Desenclos, and A. M. Courouce. 2002. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. Transfusion 42:980-988.
73. Prensa Libre. 1996. Niño muere por contagio de sida en hospital de occidente. 3 March 1996. Prensa Libre, Guatemala City, Guatemala.
74. Prensa Libre. 1999. IGSS analizara sangre existente en bancos, ante caso de SIDA denunciado por paciente. 1 February 1999. Prensa Libre, Guatemala City, Guatemala.
75. Qelemann, W. M., M. D. Teixeira, G. C. Verissimo da Costa, J. Borges-Pereira, J. D. F. De Castro, J. R. Coura, and J. M. Peralta. 1998. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease. J. Clin. Microbiol. 36:2423-2427.
76. Rios, C. R. 1992. Regimen legal de bancos de sangre en America Latina: malaria, Chagas y hepatitis B. Organizacion Panamericana de la Salud, Serie Informes Tecnicos No. 18. OPS, Washington, D.C.
77. Roth, W. K., S. Buhr, C. Drosten, and E. Seifred. 2000. NAT and viral safety in blood transfusion. Vox Sang. 78(Suppl.):257-259.
78. Saez-Alquezar, A., A. O. Luquetti, J. Borges-Pereira, E. M. Furtado, M. F. S. Gadelha, M. T. Garcia-Sapata, and A. H. S. Arruda. 1997. Estudo multicéntrico: avaliacao do desempenho de conjuntos diagnosticos de hemaglutinacao indireta, disponiveis no Brasil, para o diagnostico sorologico da infeccao pelo Trypanosoma cruzi. Rev. Patol. Trop. 26:343-374.
79. Saez-Alquezar, A., M. M. Otani, C. C. Sabino, G. Ribeiro dos Santos, N. Salles, and D. F. Chamone. 1998. Evaluation of the performance of Brazilian blood banks in testing for Chagas' diseases. Vox Sang. 74:228-231.
80. Saez-Alquezar, A., M. M. Otani, C. C. Sabino, N. A. Salles and D. F. Dalton Chamone. 2003. Programa de control externo de la calidad en serologia desarrollados en America Latina con el apoyo de la OPS entre 1997 y 2000. Rev. Panam. Salud Publica 13:91-102.
81. Saez-Alquezar, A., M. Murta, W. Pereira Marquez, and G. Rodriguez da Silva. 2003. Resultados de un programa de control de calidad externo del tamizaje serologico de anticuerpos contra el Trypanosoma cruzi en donantes de sangre de Brazil. Rev. Panam. Salud Publica 13:129-137.
82. Saez-Alquezar, A., N. A. Salles, and E. C. Sabino. 1995. Serological diagnosis of Chagas disease in blood bank. Mem. Inst. Oswaldo Cruz 90(Suppl.):34-35.
83. Salles, N. A., E. C. Sabino, C. C. Barreto, A. Barreto, M. M. Otani, and D. F. Chamone. 2003. Descarte de bolsas de sangue e prevalencia de doencas infecciosas em doadores de sangue da Fundacao Pro-Sangue/ Hemocentro de Sao Paulo. Rev. Panam. Salud Publica 13:111-116.
84. Salles, N., E. C. Sabino, M. G. Cliquet, J. Eluf-Neto, A. Mayer, A. C. Almeida-Neto, M. C. Mendonca, P. Dorliach-Llacer, D. F. Chamone, and A. Saez-Alquezar. 1996. Risk of exposure to Chagas disease among seroreactive Brazilian blood donors. Transfusion 36:969-73.
85. Schenone, H., M. C. Contreras, P. Salinas Tapia, and L. Sandoval Sepulveda. 1995. Epidemiologia de la enfermedad de Chagas en Chile. Frecuencia de infeccion humana por Trypanosoma cruzi por grupos de edad y regiones. Bol. Chile Parasitol. 50:84-86.
86. Schmidt, P. J. 1997. US blood safety. Transfusion Today 10:114.
87. Schmunis, G. A. 1991. Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in the endemic and non endemic countries. Transfusion 31:547-557.
88. Schmunis, G. A., F. Zicker, F. Pinheiro, and D. Brandling-Bennett. 1998. Risk of transfusion transmitted infectious diseases in Central and South America. Emerg. Infect. Dis. 4:5-11.
89. Schmunis, G. A., F. Zicker, A. Del Pozo, and E. Segura. 2000. Blood transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion 40:1048-1053.
90. Schmunis, G. A., F. Zicker, J. R. Cruz, and P. Cuchi. 2001. Safety of the blood supply for infectious diseases in Latin American countries. Am. J. Trop. Med. Hyg. 65:924-930.
91. Schreiber, G. B., M. P. Busch, S. H. Kleinman, and J. J. Korelitz. 1996. The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334:1685-1690.
92. Siglo Veintiuno. 1997. Nacional. Elevan a juicio oral primera demanda por contagio de SIDA. 14 Noviembre 1997. Siglo Veintiuno, Guatemala City, Guatemala.
93. Sharma, U. K., S. L. Stramer, D. J. Wrigth, S. A. Glynn, S. Hermansen, G. B. Shreiber, S. H. Kleinman, and M. P. Bush for the Retrovirus Epidemiology Donor Study. 2003. Impact of changes in viral marker screening assay. Transfusion 43:202-214.
94. Soldan, K., J. A. Barbara, M. E. Ramsay, and A. J. Hall. 2003. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang. 84:274-286.
95. Sookvian, S., G. Castano, T. Castiglioni, S. Pilar, P. Videz, J. Gonzalez, and B. Frider. 1997. Problematica de la infeccion por el virus de la hepatitis C en donantes de sangre. Medicina (Buenos Aires) 55:699-707.
96. Stramer, S. L. 2004. Viral diagnostic in the arena of blood donor screening. Vox Sang. 87(Suppl. 2):S180-S183.
97. Szalassy, C. 1990. Calculations on present and projected blood needs, p. 27-30. In S. R. Hollan, W. Wagstaff, J. Leikola, and F. Lothe (ed.), Management of blood services. World Health Organization, Geneva, Switzerland.
98. The Globe and Mail. 1995. Krever urges tainted-blood warning. 2 February 1995. The Globe and Mail, Toronto, Canada.
99. The Globe and Mail. 1996. Ottawa denies Krever key data. 15 November 1996. The Globe and Mail, Toronto, Canada.
100. The New York Times International. 1996. China concedes blood product contained AIDS virus. 25 October 1996. The New York Times, New York, N.Y.
101. The New York Times International. 1996. Japan arrests doctor in case of bad blood. 30 August 1996. The New York Times, New York, N.Y.
102. The Washington Post. 1997. French tainted-blood case. 15 March 1997. The Washington Post, Washington, D.C.
103. The Washington Post. 1997. Head of largest blood center resigns amid probe. 5 July 1997. The Washington Post, Washington, D.C.
104. The World Bank. 1993. World development report 1993. Investing in health. World Development Indicators, p. 25-36. Oxford University Press, New York, N.Y.
105. The World Bank. 1993. World development report. Investing in Health. World development indicators. Appendix B. The global burden of disease, p. 213-225. Oxford University Press, New York, N.Y.
106. Tobler, L. H., S. R. Lee, S. L. Stramer, J. Peterson, R. Kochestky, K. Watanabe, S. Quan, A. Polito, and M. P. Bush for the Retrovirus Epidemiology Donor Study. 2000. Performance of second-and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Transfusion 44:917-923.
107. Tobler, L. H., S. L. Stramer, S. R. Lee, B. L. Masecar, J. E. Peterson, E. A. Davis, W. E. Andrews, J. P. Brodsky, S. H. Kleiman, B. H. Phelps, and M. P. Busch. 2003. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood donor screening. Transfusion 43:1452-1459.
108. Tosti, M. E., S. Solinas, D. Prati, L. Salvaneschi, M. Manca, M. Francesconi, M. Ciuffreda, G. Girelli, and A. Mele. 2002. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br. J. Haematol. 117:215-219.
109. United Nations. 2003. World population prospects: The 2002 revision. Estimates 1950-2000. POP/DB/WPP/Rev.2002/2/FI. United Nations, New York, N.Y.
110. United States General Accounting Office. 1997. Report to the ranking Minority Member Committee on Commerce, House of representatives. Blood supply. FDA oversight and remaining issues of safety. GAO/ PEMED-97-1. General Accounting Office, Washington, D.C.
111. Uttendaelle, S., H. Claeys, W. Mertens, H. Verhaert, and C. Vermylen. 1994. Evaluation of third generation screening and confirmatory assays for HCV antibodies. Vox Sang. 66:122-129.
112. Vazquez, M., S. Vidal, C. Espinoza, I. Palomo, M. Torres, C. Alvaro, M. Canales, A. M. Salinas, J. Pereira, and G. Jerez. 1999. Utilidad de una encuesta para identificar donantes de sangre de zonas no endemicas, potencialmente infectadas con Trypanosoma cruzi. Parasitol Dia. 23:125-129.
113. Velati, C., L. Romano, L. Baruffi, M. Pappalettera, V. Carreri, and A. R. Zanetti. 2002. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion 42:989-993.
114. Voak, D., A. Caffrey, J. A. J. Barbara, A. Pollock, M. Scott and M. C. Contreras. 1998. Affordable safety for the blood supply in developed and developing countries. Transfusion Med. 8:73-76.
115. Vrielink, H., P. J. Reesink, P. J. M. van den Burg, H. I. Zaaijer, H. T. M. Cuypers, P. N. Lelie, and C. L. van der Poel. 1997. Performance of three generations of anti-hepatitis C virus enzime-linked immunobsorbent assays in donors and patients. Transfusion 37:845-849.
116. Weinberg, P. D., J. Hounshell, L. A. Sherman, J. Godwin, S. Ali, C. Tomori, and C. L. Bennett. 2002. Legal, financial, and public health consequences of HIV contamination of blood products in the 1980s and 1990s. Ann. Intern. Med. 136:312-319.
117. Watson, R. 2003. E.U. sets standards for safe blood products. Br. Med. J. 326:11.
118. Wendell, S., and A. Gonzaga. 1993. Chagas' disease and blood transfusion: a new world problem? Vox Sang. 54:1-12.
119. WHO/UNAIDS. 1998. Operational characteristics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera. Report 9-10. WHO/BLS/98.1. World Health Organization, Geneva, Switzerland.
120. WHO/UNAIDS. 1999. Operational characteristics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera. Report 11. WHO/BLS/99.1. World Health Organization, Geneva, Switzerland.
121. Williamson, L. M., S. Lowe, E. Love, H. Cohen, K. Soldan, D. B. L. McClelland, P. Skacel and J. Barbara. 1998. The serious hazards of transfusion (SHOT) Annual Report 1996/7. SHOT, London, United Kingdom.
122. World Health Organization. 1975. Utilization and supply of human blood and blood products. Twenty-eighth World Health Assembly. Resolution WHA28.72. World Health Organization, Geneva, Switzerland.
123. World Health Organization. 1991. Control of Chagas Disease. WHO Tech Rep. Ser. 811:32.
124. World Health Organization. 2000. The World Health Report 2000. Health systems: improving performance, p. 164-175. World Health Organization, Geneva, Switzerland.
125. World Health Organization. 2001. Hepatitis B surface antigen assays: operational characteristics. Report 1. WHO/BCT/BTS/01. World Health Organization, Geneva, Switzerland.
126. World Health Organization. 2001. Hepatitis C assays: operational characteristics (phase 1). Report 2. WHO/BCT/BTS/01.5. World Health Organization, Geneva, Switzerland.
127. World Health Organization. 2002. The World Health Report 2002. Reducing risk, promoting healthy life, p. 170-197. World Health Organization, Geneva, Switzerland.
128. World Health Organization. 2002. Control of Chagas disease. WHO Tech. Rep. Ser. 905:24-28.
129. Zuna, H., C. La Fuente, and E. Valdez. 1985. Estudio prospectivo de la transmisión del Trypanosoma cruzi por via sanguinea en Bolivia. Ann. Soc. Belge Med. Trop. 65(Suppl. 1):107-113.